Freeman Technology Experts to Present on Powder Characterisation and Critical Powder Handling Issues at 7th World Congress on Particle Technology (WCPT7)

Tim Freeman, Managing Director, and Dr Xiaowei Fu, Product Specialist at Freeman Technology, will deliver four oral presentations relating to aspects of powder characterisation and critical powder handling issues at the 7th World Congress on Particle Technology (WCPT7) taking place from 19-22 May 2014 in Beijing, China.

Tim Freeman is an invited speaker at the Particle Design: Formulation and Processing session, where he will present ‘A QbD Approach to Continuous Tablet Manufacture’. This talk will focus on the use of powder characterisation to measure material properties that directly correlate with the quality attributes of a finished product to support the development of continuous processes.

In further presentations, Tim will cover the topics of ‘Understanding the mechanisms of particle interactions and powder flow’ and ‘Powder Flow Characterization – the need for an instrumental, multivariate approach’

Dr Xiaowei Fu will speak about ‘Measurement and quantification of caking in powders’ – an issue widely encountered by powder processors in all industries.

In addition, new research on quantifying the effect of flow additives will also be presented in the poster session. Flow additives, lubricants or glidants are often used in order to improve processability of powders.  Magnesium Stearate is used extensively as a lubricant in manufacturing pharmaceutical tablets and the poster will describe a study designed to gain greater understanding of the effects of this additive.

About Freeman Technology

Freeman Technology specialises in systems for measuring the flow properties of powders and has over a decade of experience in powder flow and powder characterisation. Expert teams provide detailed know-how alongside the company’s universal powder tester, the FT4 Powder Rheometer®.

The FT4 Powder Rheometer uses patented dynamic methodology, a fully automated shear cell and several bulk property tests to quantify powder properties in terms of flow and processability. Systems are installed around the world across many different industries. They deliver data that maximise process and product understanding, accelerating R&D and formulation towards successful commercialisation, and supporting the long term optimisation of powder processes.

Freeman Technology’s headquarters are in Gloucestershire, UK, with a wholly owned subsidiary in the USA and distribution partners in Brazil, Canada, China, France, India, Ireland, Japan and South-East Asia. In 2007 the company received the Queen’s Award for Enterprise in Innovation and in 2012 the Queen’s Award for Enterprise in International Trade

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Freeman Technology. (2019, February 08). Freeman Technology Experts to Present on Powder Characterisation and Critical Powder Handling Issues at 7th World Congress on Particle Technology (WCPT7). AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=40874.

  • MLA

    Freeman Technology. "Freeman Technology Experts to Present on Powder Characterisation and Critical Powder Handling Issues at 7th World Congress on Particle Technology (WCPT7)". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=40874>.

  • Chicago

    Freeman Technology. "Freeman Technology Experts to Present on Powder Characterisation and Critical Powder Handling Issues at 7th World Congress on Particle Technology (WCPT7)". AZoM. https://www.azom.com/news.aspx?newsID=40874. (accessed November 21, 2024).

  • Harvard

    Freeman Technology. 2019. Freeman Technology Experts to Present on Powder Characterisation and Critical Powder Handling Issues at 7th World Congress on Particle Technology (WCPT7). AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=40874.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.